BioArray News GenomeWeb News Premium Content Existing subscribers login here. New to BioArray News? For a trial subscription click here.

Ditching Slow-Growth, Costly Microarray Biz,
Nanogen Seeks Buyer with ‘Deeper Pockets’

[September 25, 2007]

By Justin Petrone

Last December it was GE Healthcare who pulled the plug on its CodeLink bioarray business, calling the platform unsuitable for clinical applications. Now it is Nanogen who has decided that the fabled array-based diagnostics market could materialize in the future, but not quickly enough to offset the high costs that are keeping the San Diego firm from reaching profitability.

Login | Subscribe